Table 2.
The global assessment to treatment of either Biobran or placebo.
| Biobran (n = 19) | Placebo (n = 20) | |
|---|---|---|
| Markedly improved | 4 (21.1%)∗ | 2 (10.0%) |
| Slightly improved | 8 (42.1%)∗ | 4 (20.0%) |
|
| ||
| Unchanged | 6 (31.6%) | 11 (55.0%) |
| Not so good | 1 (5.3%) | 2 (10.0%) |
| Deteriorated | 1 (5.0%) | |
*P = 0.0465 versus placebo.